Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan

Overview of attention for article published in BMC Pediatrics, October 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Dimensions has found 4 publications that cite this research output.

Article in Arquivos de Gastroenterologia (March 2023)

Article in The Journal of Medical Investigation (January 2023)

Article in Yonsei Medical Journal (June 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.